Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services
His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors
The foray into this new segment will help Vimta to enter into the growing CDMO business of biologics and peptides
Sumitomo Chemical began its nucleic acid drug substance contract manufacturing business in 2013
Amaran Biotech boasts Taiwan’s first fully automated robotic aseptic filling line, offering high-quality and low-waste filling solutions for high-value pharmaceuticals
The acquisition aligns with Granules' vision to enter the rapidly expanding peptide-based anti-diabetic and anti-obesity market
A new initiative to contribute to enhancing drug discovery capabilities in the field of gene and cell therapy in Japan
e brings over 27+ years of rich pharmaceutical experience
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
Subscribe To Our Newsletter & Stay Updated
